- Drugs
- Monday, 04 May 2020
Pharmaceutics International Selected as A Winner of Two GH&P Awards
Pharmaceutics International, Inc. (Pii), a US-based Contract Development and Manufacturing Organization (CDMO) today announced it has won the 2020 CDMO Leadership Award and was named the Most Innovative Company in Dosage Solutions by Global Health & Pharma Magazine.
"We are honored to be recognized in these two categories. Pii has an extensive range of technologies, skilled personnel and Pharmaceutics Know-How™, to enable the rapid development and reliable production of high-quality sterile and oral dosage forms. It is extremely gratifying to have our innovation, accomplishments and commitment to partners and patients acknowledged," said Dr. Kurt R. Nielsen, Pii's President and CEO.
According to GH&P, "Biotechnology is a huge, varied and ever-growing industry. Operating and succeeding in such an environment which, in many ways, demands excellence at every turn is - it goes without saying - incredibly difficult, yet there are businesses that have learned to thrive under such conditions. To harness innovation and deliver results, driving the greater industry onwards." Jazmin Collins, GH&P Awards Coordinator, commented "Regardless of their size or location, we honor companies from across this vibrant and talented sector."
Related Industry Updates
Asia and Africa Lateral Flow Assay Market is expected to reach US$ 2,159.62 million by 2028
May 23, 2023
Esteve acquires German proprietary, specialty, hospital-focused company Riemser and expands its presence in Europe
Jan 08, 2020
Enteral and Parenteral Medical Nutrition Market is expected to reach US$ 25,476.86 million by 2028
Jun 15, 2023
Canna Hemp and The Growing Demand for Quality CBD Wellness Products
Mar 20, 2020
Fluorine-18 Market is expected to reach US$ 2.41billion by 2030
Feb 06, 2024
Vitamin K2 Market is expected to reach US$ 11,60,779.02 Thousands by 2030
Oct 11, 2023
Homeopathy Market is expected to reach US$ 18,069.91 million by 2030
Aug 09, 2023